Comparer des méthodes

	Échelle de douleur pelvienne féminine	Questionnaire sur le syndrome des ovaires polykystiques	Outil de dépistage des symptômes prémenstruels
Domaine	Obstétrique et gynécologie	Obstétrique et gynécologie	Obstétrique et gynécologie
Famille	Process / pipeline	Process / pipeline	Process / pipeline
Année d'origine	2001	1998	2003
Auteur d'origine	Multiple developers	Cronin, L., Guyatt, G., Griffith, L., Wong, E., Azziz, R., Young, D., & Kjerulff, K.	Steiner, M., Macdougall, M., & Brown, E.
Type	Self-report	Self-report	Self-report
Source fondatrice	Jones, G. L., Kennedy, S. H., Barnard, A., Wong, J., & Jenkinson, C. (2001). Development of an endometriosis quality-of-life instrument: The Endometriosis Health Profile-30. Obstetrics & Gynecology, 98(2), 258-264.	Cronin, L., Guyatt, G., Griffith, L., Wong, E., Azziz, R., Young, D., & Kjerulff, K. (1998). Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). The Journal of Clinical Epidemiology, 51(11), 1235-1246.	Steiner, M., Macdougall, M., & Brown, E. (2003). The Premenstrual Symptoms Screening Tool (PSST) for clinicians. Archives of Women's Mental Health, 6(3), 203-209.
Alias	FPPS, Pelvic Pain Questionnaire	PCOSQ, PCOS Quality of Life	PSST, Premenstrual Symptom Screening
Apparentées	3	3	3
Résumé	The Female Pelvic Pain Scale (FPPS) is a standardized self-report instrument designed to assess the severity and functional impact of pelvic pain conditions in women, including dysmenorrhea, pelvic inflammatory disease, interstitial cystitis, and pelvic pain of unclear etiology. By measuring pain intensity, location, timing, and associated functional limitations, the FPPS enables clinicians to quantify baseline pain burden and track treatment response.	The Polycystic Ovary Syndrome Questionnaire (PCOSQ) is a 26-item self-report instrument developed to measure quality of life in women with polycystic ovary syndrome (PCOS). Created by Cronin and colleagues in 1998, the PCOSQ is disease-specific, assessing five dimensions uniquely relevant to PCOS: emotional effects, body hair, weight, infertility, and menstrual problems. It enables clinicians and researchers to evaluate the multidimensional impact of PCOS and monitor outcomes of lifestyle, hormonal, and reproductive interventions.	The Premenstrual Symptoms Screening Tool (PSST) is a brief, 19-item self-report questionnaire designed to screen for premenstrual dysphoric disorder (PMDD) and assess the severity of premenstrual symptoms. Developed by Steiner, Macdougall, and Brown in 2003, the PSST efficiently identifies women with clinically significant cyclical mood and physical symptoms warranting diagnostic evaluation and potential pharmacological or psychological treatment.